NDC 17856-0631-2 - Atovaquone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0631
- Requested NDC
- 17856-0631-2
- Package NDCs from labels
- 17856-0631-2, 17856-0631-1
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atovaquone - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0631-1 | Atovaquone | 72 in 1 BOX, UNIT-DOSE | SUSPENSION | 72 | 2 | |
| 17856-0631-2 | Atovaquone | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0631 | ATOVAQUONE (ATOVAQUONE) SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, 2 package rows | 20250514_f99a8a0c-2b42-4da0-8f5a-e963fc619e8b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0631-1 | ML - Milliliter | 17856-0631 | 086ed185-511b-45fb-9184-aeb9bd040a65 | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Atovaquone Oral Suspension | ATOVAQUONE | KVK-Tech, Inc. | b31ff20a-c363-4be0-9bc0-3081c163b63c | 2026-06-16 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| ATOVAQUONE | ATOVAQUONE | AvKARE | 54423fee-da60-25dc-e063-6294a90a2552 | 2026-06-14 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
| Atovaquone | ATOVAQUONE | Camber Pharmaceuticals, Inc. | 2445304e-4b4e-4358-b098-31f3c49c52ef | 2026-06-10 | Warnings, Adverse reactions | ANDA210692 31722-629 308429 53e3680b-e7d0-82b4-e063-6394a90af9e8 2445304e-4b4e-4358-b098-31f3c49c52ef Y883P1Z2LT |
| MALARONE | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | GlaxoSmithKline LLC | fc22e8d8-3bfb-4f70-a599-dd81262a4887 | 2026-06-10 | Warnings, Adverse reactions | Y883P1Z2LT |
| XIMONTH Fungi Free Bee Venom Nail Soothing Serum | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 53bab969-8407-6334-e063-6294a90aa5d1 | 2026-06-08 | Warnings | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| WHITENING SUNSCREENANTI WRINKLE | WHITENING SUNSCREENANTI WRINKLE | Shantou Oushiya Biotechnology Co.,Ltd | 524384e9-b3f8-4c13-e063-6394a90a8973 | 2026-05-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Hospira, Inc. | 3a6422e1-feee-4095-8883-2b0837039e6e | 2026-05-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | LKG8494WBH |
| atovaquone | ATOVAQUONE | Glenmark Pharmaceuticals Inc., USA | 9045ba6f-938e-4717-bfa2-a3efe52f04cd | 2026-05-06 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Multi Flower | AESCULUS CARNEA, FLOS, AESCULUS HIPPOCASTANUM, FLOS, AGRIMONIA EUPATORIA, FLOS, BROMUS RAMOSUS, FLOS, CALLUNA VULGARIS, FLOS, CARPINUS BETULUS , FLOS, CASTANEA SATIVA, FLOS, CENTAURIUM UMBELLATUM, FLOS, CERATOSTIGMA WILLMOTTIANUM, FLOS, CICHORIUM INTYBUS, FLOS, CLEMATIS VITALBA, FLOS, CLEMATIS VITALBA, FLOS, FAGUS SYLVATICA, FLOS, GENTIANELLA AMARELLA, FLOS, HELIANTHEMUM NUMMULARIUM, FLOS, ILEX AQUIFOLIUM, FLOS, IMPATIENS GLANDULIFERA, FLOS, LARIX DECIDUA, FLOS, LONICERA CAPRIFOLIUM, FLOS | Energique, Inc. | 09c059e7-f748-402c-8447-af5b61169c58 | 2026-05-06 | Warnings | 059QF0KO0R |
| Atovaquone | ATOVAQUONE | PAI Holdings, LLC dba PAI Pharma | df6086d3-6100-422a-bf23-e9610027749b | 2026-04-30 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| ATOVAQUONE | ATOVAQUONE | Amneal Pharmaceuticals LLC | b7398fcf-522a-488a-8dd6-051561f62804 | 2026-04-29 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Atovaquone and Proguanil Hydrochloride Pediatric | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC | Glenmark Pharmaceuticals Inc.,USA | 4b80d087-eaa7-448f-967e-344de7f16436 | 2026-04-24 | Warnings, Adverse reactions | Y883P1Z2LT |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| MEPRON | ATOVAQUONE | GlaxoSmithKline LLC | b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | 2026-03-20 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.